COPD: Who does, and does not, benefit from triple therapy? - Pierre Ernst
COPD: Who does, and does not, benefit from triple therapy?
Add Personal Notes
Pierre Ernst, Canada
Professor of Medicine
Faculty of Medicine
At the conclusion of this session, participants will be able to:
Adopt current COPD treatment guidelines
Recognize specific phenotypes of COPD in order to choose the preferred treatment options in different patients
Recognise the potential benefit and adverse outcomes associated with the ICS component of Triple Therapy in COPD
Become comfortable with the new triple combination inhalers being promoted for the treatment of COPD
Click to ask
There are no questions yet...
If you have any questions, please consult our
© 2023 McGill Family Physician Refresher Course